Curaleaf (OTCMKTS:CURLF – Get Rating) had its target price increased by stock analysts at Cantor Fitzgerald from $15.50 to $16.50 in a note issued to investors on Monday, Benzinga reports. The firm currently has an “overweight” rating on the stock. Cantor Fitzgerald’s price target would indicate a potential upside of 155.42% from the company’s previous close.
Several other analysts have also recently issued reports on the stock. Benchmark began coverage on shares of Curaleaf in a report on Friday, February 25th. They issued a “buy” rating and a $12.00 price target on the stock. Wolfe Research assumed coverage on shares of Curaleaf in a research report on Friday, January 7th. They set a “peer perform” rating on the stock. Stifel Nicolaus lowered their price objective on Curaleaf from C$31.00 to C$25.00 in a report on Monday, March 7th. Finally, Needham & Company LLC reduced their target price on Curaleaf from $17.00 to $15.00 and set a “buy” rating on the stock in a report on Friday, March 4th. Two research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat, Curaleaf has an average rating of “Buy” and an average price target of $19.72.
CURLF opened at $6.46 on Monday. Curaleaf has a twelve month low of $5.35 and a twelve month high of $15.47. The company has a fifty day simple moving average of $6.81 and a 200 day simple moving average of $8.30.
Curaleaf Company Profile (Get Rating)
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates in two segments, Cannabis Operations and Non-Cannabis Operations. The Cannabis Operations segment engages in the production and sale of cannabis through retail and wholesale channels. The Non-Cannabis Operations segment provides professional services, including cultivation, processing, and retail know-how and back-office administration, intellectual property licensing, real estate leasing services, and lending facilities to medical and adult-use cannabis licensees under management service agreements.
- Get a free copy of the StockNews.com research report on Curaleaf (CURLF)
- Schwab Stock Can Be Caught Down Here
- Snap Up Some Snap-On On Post-Earnings Weakness
- Time to Buy any Dip in Prologis Stock
- 3 Resilient Stocks to Buy for Retirement
- MarketBeat: Week in Review 4/18 – 4/22
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.